You are here

  • Home
  • Online First
  • Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study

Article info

Article menu
Download PDFPDF
Rheumatoid arthritis
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study

Authors

  • Shahab Abtahi Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Johanna H M Driessen Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsNUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Andrea M Burden Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsInstitute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH-Zurich, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Patrick C Souverein Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Joop P van den Bergh Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The NetherlandsFaculty of Medicine and Life Sciences, Hasselt University, Hasselt, BelgiumDepartment of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands PubMed articlesGoogle scholar articles
  • Tjeerd P van Staa Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCentre for Health Informatics, Division of Informatics, Imaging and Data Science, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • Annelies Boonen Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The NetherlandsCare and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  • Frank de Vries Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Centre, Maastricht, The NetherlandsDivision of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The NetherlandsCardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The NetherlandsMRC Epidemiology Lifecourse Unit, Southampton General Hospital, Southampton, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Frank de Vries, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO BOX 80082, 3508 TB, Utrecht, The Netherlands; f.devries{at}uu.nl
View Full Text

Citation

Abtahi S, Driessen JHM, Burden AM, et al
Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study
Annals of the Rheumatic Diseases Published Online First: 11 December 2020. doi: 10.1136/annrheumdis-2020-218758

Publication history

  • Received July 31, 2020
  • Revised November 12, 2020
  • Accepted November 17, 2020
  • First published December 11, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.